Literature DB >> 12545679

Endophthalmitis in patients with disseminated fungal disease.

Stephen S Feman1, John C Nichols, Sophia M Chung, Todd A Theobald.   

Abstract

BACKGROUND/
PURPOSE: Fungal endophthalmitis caused by dissemination from extraocular fungal infections has been reported to vary between 9% and 45%. However, recent clinical experience disagrees with that. This study is an investigation of patients in an inner city teaching hospital, the risks associated with endogenous fungal endophthalmitis, and this incidence.
METHODS: All ophthalmology consultations between February 1995 and August 2000 that might be associated with disseminated fungal infection were examined in a prospective manner. Patients were excluded if there was no evidence of a positive fungal culture from any site at any time. Visual symptoms were recorded along with ophthalmologic and systemic examination features. Information was gathered, including the identity of cultured organisms, the sites from which the organisms were obtained, and the patients' disposition.
RESULTS: During this interval, 170 consultation requests contained the words "endophthalmitis" or "retinitis" and/or indicated concern about disseminated fungal infections. Extraocular fungal infections were found in 114 patients, but only 82 of them had evidence of systemic dissemination. Some patients had more than one organism. The following are listed in decreasing frequency of occurrence: Candida albicans, Torulopsis glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Aspergillus niger, and others. Only two patients had evidence of chorioretinitis and progressed to fungal endophthalmitis.
CONCLUSIONS: Endophthalmitis was rare among these patients with known fungal infections. Less than 2% had any related ophthalmic manifestations. Nevertheless, since treatment can save vision, evidence of intraocular infection should be sought as eagerly as before.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12545679      PMCID: PMC1358948     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  5 in total

1.  Risk factors for nosocomial candidemia: a case-control study in adults without leukemia.

Authors:  J Bross; G H Talbot; G Maislin; S Hurwitz; B L Strom
Journal:  Am J Med       Date:  1989-12       Impact factor: 4.965

2.  Prospective study of Candida endophthalmitis in hospitalized patients with candidemia.

Authors:  R G Brooks
Journal:  Arch Intern Med       Date:  1989-10

3.  Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study.

Authors:  S P Donahue; C M Greven; J J Zuravleff; A W Eller; M H Nguyen; J E Peacock; M W Wagener; V L Yu
Journal:  Ophthalmology       Date:  1994-07       Impact factor: 12.079

4.  Endogenous endophthalmitis among patients with candidemia.

Authors:  D W Parke; D B Jones; L O Gentry
Journal:  Ophthalmology       Date:  1982-07       Impact factor: 12.079

5.  Ocular involvement in patients with fungal infections.

Authors:  P J McDonnell; J M McDonnell; R H Brown; W R Green
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

  5 in total
  21 in total

1.  Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Bo Bo Win Maung; Robert S Mansbach; Michael R Hodges; Malcolm A Finkelman; Karen Joy Shaw; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Candidemia complicated by endophthalmitis: a prospective analysis.

Authors:  S Kannangara; D Shindler; D Y Kunimoto; B Sell; J A DeSimone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

3.  Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection.

Authors:  Hideaki Kato; Yukihiro Yoshimura; Yoshihiro Suido; Kazuo Ide; Yoshifumi Sugiyama; Kasumi Matsuno; Hideaki Nakajima
Journal:  Infection       Date:  2018-06-29       Impact factor: 3.553

4.  Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis.

Authors:  Ying-Lien Chen; Shang-Jie Yu; Hsin-Yu Huang; Ya-Lin Chang; Virginia N Lehman; Fitz Gerald S Silao; Ursela G Bigol; Alice Alma C Bungay; Anna Averette; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2014-01-17

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Candida endophthalmitis: A critical diagnosis in the critically ill.

Authors:  L Au; K Guduru; G Lipscomb; S P Kelly
Journal:  Clin Ophthalmol       Date:  2007-12

7.  A case of endogenous trichosporon endophthalmitis treated with micafungin and voriconazole.

Authors:  Harpreet Walia; Veronica T Tucci; John N Greene; Jennifer Tordilla-Wadia; Patrick Kelty; Sandeep Walia
Journal:  J Glob Infect Dis       Date:  2009-01

8.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

9.  Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis.

Authors:  Jeong Hun Bae; Sung Chul Lee
Journal:  Jpn J Ophthalmol       Date:  2015-07-28       Impact factor: 2.447

10.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.